STP0404
Asset
Allosterically inhibits HIV-1 integrase, disrupting viral maturation and replication.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1HIV-1 infection
Phase 2, koreabiomed.com, 7 Oct 2026
In the full profile
- Owner and partners1
- Competitors1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.